Juan Wang

Person

Foster City, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Lyophilized formulations for factor Xa antidote
- Patent number 11,028,382
- Issue date Jun 8, 2021
- Alexion Pharmaceuticals, Inc.
- Juan Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE
- Publication number 20210284986
- Publication date Sep 16, 2021
- Alexion Pharmaceuticals, Inc.
- Juan Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE
- Publication number 20200299667
- Publication date Sep 24, 2020
- Portola Pharmaceuticals, Inc.
- Juan Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE
- Publication number 20200299668
- Publication date Sep 24, 2020
- Portola Pharmaceuticals, Inc.
- Juan Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE
- Publication number 20180320160
- Publication date Nov 8, 2018
- Portola Pharmaceuticals, Inc.
- Juan Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE
- Publication number 20160237420
- Publication date Aug 18, 2016
- Portola Pharmaceuticals, Inc.
- Juan Wang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SOLID COMPOSITION FOR CONTROLLED RELEASE OF IONIZABLE ACTIVE AGENTS...
- Publication number 20130172374
- Publication date Jul 4, 2013
- Portola Pharmaceuticals, Inc.
- Chandir Ramani
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITION AND DOSAGE FORMS OF ELINOGREL AND METHOD...
- Publication number 20130165459
- Publication date Jun 27, 2013
- NORVARTIS PHARMA AG
- Juan Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DOSAGE FORMS OF ELINOGREL AND METHODS OF INJECTABLE ADMINISTRATION...
- Publication number 20130131089
- Publication date May 23, 2013
- Portola Phamaceuticals Inc.
- Hui Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
[4-(6-FLUORO-7-METHYLAMINO-2,4-DIOXO-1,4-DIHYDRO-2H-QUINAZOLIN-3-YL...
- Publication number 20120129876
- Publication date May 24, 2012
- Portola Pharmaceuticals, Inc.
- Emma Sharp
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE FORMS OF A FACTOR XA INHIBITOR
- Publication number 20110160250
- Publication date Jun 30, 2011
- Millennium Pharmaceuticals, Inc.
- Anjali Pandey
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOLID COMPOSITION FOR CONTROLLED RELEASE OF IONIZABLE ACTIVE AGENTS...
- Publication number 20100151019
- Publication date Jun 17, 2010
- Portola Pharmaceuticals, Inc.
- Chandir Ramani
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
[4-(6-FLUORO-7-METHYLAMINO-2,4-DIOXO-1,4-DIHYDRO-2H-QUINAZOLIN-3-YL...
- Publication number 20090156620
- Publication date Jun 18, 2009
- Portola Pharmaceuticals, Inc.
- Emma Sharp
- C07 - ORGANIC CHEMISTRY
Information Patent Application
[4-(6-FLUORO-7-METHYLAMINO-2,4-DIOXO-1,4-DIHYDRO-2H-QUINAZOLIN-3-YL...
- Publication number 20090042916
- Publication date Feb 12, 2009
- Portola Pharmaceuticals, Inc.
- Emma Sharp
- C07 - ORGANIC CHEMISTRY

Person

Patents Grantslast 30 patents

Lyophilized formulations for factor Xa antidote

Patents Applicationslast 30 patents

LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE

LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE

LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE

LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE

LYOPHILIZED FORMULATIONS FOR FACTOR XA ANTIDOTE

SOLID COMPOSITION FOR CONTROLLED RELEASE OF IONIZABLE ACTIVE AGENTS...

PHARMACEUTICAL COMPOSITION AND DOSAGE FORMS OF ELINOGREL AND METHOD...

DOSAGE FORMS OF ELINOGREL AND METHODS OF INJECTABLE ADMINISTRATION...

[4-(6-FLUORO-7-METHYLAMINO-2,4-DIOXO-1,4-DIHYDRO-2H-QUINAZOLIN-3-YL...

CRYSTALLINE FORMS OF A FACTOR XA INHIBITOR

SOLID COMPOSITION FOR CONTROLLED RELEASE OF IONIZABLE ACTIVE AGENTS...

[4-(6-FLUORO-7-METHYLAMINO-2,4-DIOXO-1,4-DIHYDRO-2H-QUINAZOLIN-3-YL...

[4-(6-FLUORO-7-METHYLAMINO-2,4-DIOXO-1,4-DIHYDRO-2H-QUINAZOLIN-3-YL...